$ANIK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anika Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Anika Therapeutics, Inc.. Get notifications about new insider transactions in Anika Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Buy | M | 3.13 | 10,000 | 31,250 | 19,000 | 9 K to 19 K (+111.11 %) |
| Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | M | 0.99 | 12,500 | 12,375 | 0 | |
| Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | M | 0.91 | 13,500 | 12,234 | 0 | |
| Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | M | 3.13 | 10,000 | 31,250 | 0 | |
| Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Sell | S | 9.63 | 22,700 | 218,601 | 13,300 | 36 K to 13.3 K (-63.06 %) |
| Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Buy | M | 0.99 | 12,500 | 12,375 | 36,000 | 23.5 K to 36 K (+53.19 %) |
| Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Buy | M | 0.91 | 13,500 | 12,234 | 23,500 | 10 K to 23.5 K (+135.00 %) |
| Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Sell | S | 9.59 | 9,000 | 86,270 | 10,000 | 19 K to 10 K (-47.37 %) |
| Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Buy | M | 3.13 | 10,000 | 31,250 | 19,000 | 9 K to 19 K (+111.11 %) |
| Nov 17 2004 | ANIK | Anika Therapeutics ... | Toth Carol A | Vice President, R & ... | Option Exercise | A | 9.64 | 75,000 | 723,000 | 75,000 | |
| Nov 17 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | M | 4.25 | 10,000 | 42,500 | 0 | |
| Nov 17 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Sell | S | 9.55 | 1,874 | 17,905 | 0 | 1.9 K to 0 (-100.00 %) |
| Nov 17 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Sell | S | 9.51 | 1,000 | 9,514 | 9,000 | 10 K to 9 K (-10.00 %) |
| Nov 17 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Buy | M | 4.25 | 10,000 | 42,500 | 10,000 | 0 to 10 K |
| Nov 17 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Sell | S | 9.60 | 10,726 | 103,015 | 0 | 10.7 K to 0 (-100.00 %) |
| Nov 05 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | M | 9.22 | 1,530 | 14,107 | 0 | |
| Nov 05 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | M | 5.19 | 3,000 | 15,563 | 0 | |
| Nov 05 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Sell | S | 9.69 | 4,500 | 43,620 | 30 | 4.5 K to 30 (-99.34 %) |
| Nov 05 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Buy | M | 9.22 | 1,530 | 14,107 | 4,530 | 3 K to 4.5 K (+51.00 %) |
| Nov 05 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Buy | M | 5.19 | 3,000 | 15,563 | 3,000 | 0 to 3 K |
| Nov 05 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | M | 9.22 | 1,530 | 14,107 | 0 | |
| Nov 05 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | M | 5.19 | 3,000 | 15,563 | 0 | |
| Nov 05 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Sell | S | 9.69 | 4,500 | 43,620 | 30 | 4.5 K to 30 (-99.34 %) |
| Nov 05 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Buy | M | 9.22 | 1,530 | 14,107 | 4,530 | 3 K to 4.5 K (+51.00 %) |
| Nov 05 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Buy | M | 5.19 | 3,000 | 15,563 | 3,000 | 0 to 3 K |
| Oct 06 2004 | ANIK | Anika Therapeutics ... | Chen Elizabeth | Sr. VP Mktg. & Bus. ... | Option Exercise | A | 15.45 | 100,000 | 1,545,000 | 100,000 | |
| Nov 15 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | M | 1.05 | 11,800 | 12,390 | 0 | |
| Nov 15 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | M | 9.75 | 1,596 | 15,561 | 0 | |
| Nov 15 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | M | 7.63 | 2,000 | 15,250 | 0 | |
| Nov 15 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Sell | S | 9.56 | 3,500 | 33,447 | 10,696 | 14.2 K to 10.7 K (-24.65 %) |
| Nov 15 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Sell | S | 9.63 | 1,200 | 11,557 | 14,196 | 15.4 K to 14.2 K (-7.79 %) |
| Nov 15 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Buy | M | 1.05 | 11,800 | 12,390 | 15,396 | 3.6 K to 15.4 K (+328.14 %) |
| Nov 15 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Buy | M | 9.75 | 1,596 | 15,561 | 3,596 | 2 K to 3.6 K (+79.80 %) |
| Nov 15 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Buy | M | 7.63 | 2,000 | 15,250 | 2,000 | 0 to 2 K |
| Sep 29 2004 | ANIK | Anika Therapeutics ... | KNIGHT WILLIAM J | CFO | Option Exercise | M | 1.01 | 18,750 | 18,938 | 107,500 | |
| Sep 29 2004 | ANIK | Anika Therapeutics ... | KNIGHT WILLIAM J | CFO | Buy | M | 1.01 | 18,750 | 18,938 | 47,500 | 28.8 K to 47.5 K (+65.22 %) |
| Sep 17 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 13.50 | 1,500 | 20,250 | 4,000 | 5.5 K to 4 K (-27.27 %) |
| Sep 17 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 13.35 | 439 | 5,861 | 5,500 | 5.9 K to 5.5 K (-7.39 %) |
| Sep 17 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 13.34 | 2,561 | 34,164 | 5,939 | 8.5 K to 5.9 K (-30.13 %) |
| Sep 07 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Option Exercise | M | 0.99 | 9,500 | 9,405 | 47,926 | |
| Sep 07 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 13.15 | 500 | 6,575 | 8,500 | 9 K to 8.5 K (-5.56 %) |
| Sep 07 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 13.75 | 816 | 11,220 | 9,000 | 9.8 K to 9 K (-8.31 %) |
| Sep 07 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 13.74 | 234 | 3,215 | 9,816 | 10.1 K to 9.8 K (-2.33 %) |
| Sep 07 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 13.73 | 450 | 6,179 | 10,050 | 10.5 K to 10.1 K (-4.29 %) |
| Sep 07 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Buy | M | 0.99 | 9,500 | 9,405 | 10,500 | 1,000 to 10.5 K (+950.00 %) |
| Sep 02 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Option Exercise | M | 0.99 | 2,200 | 2,178 | 57,426 | |
| Sep 02 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Option Exercise | M | 0.99 | 800 | 792 | 59,626 | |
| Sep 02 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 13.04 | 2,200 | 28,688 | 1,000 | 3.2 K to 1,000 (-68.75 %) |
| Sep 02 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Buy | M | 0.99 | 2,200 | 2,178 | 3,200 | 1,000 to 3.2 K (+220.00 %) |
| Sep 02 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 13.05 | 100 | 1,305 | 1,000 | 1.1 K to 1,000 (-9.09 %) |
| Sep 02 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 13.04 | 200 | 2,608 | 1,100 | 1.3 K to 1.1 K (-15.38 %) |
| Sep 02 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 13.00 | 500 | 6,500 | 1,300 | 1.8 K to 1.3 K (-27.78 %) |
| Sep 02 2004 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Buy | M | 0.99 | 800 | 792 | 1,800 | 1,000 to 1.8 K (+80.00 %) |
| May 10 2004 | ANIK | Anika Therapeutics ... | KNIGHT WILLIAM J | Chief Financial Off ... | Option Exercise | M | 1.01 | 18,750 | 18,938 | 126,250 | |
| May 10 2004 | ANIK | Anika Therapeutics ... | KNIGHT WILLIAM J | Chief Financial Off ... | Option Exercise | M | 1.05 | 10,000 | 10,500 | 145,000 | |
| May 10 2004 | ANIK | Anika Therapeutics ... | KNIGHT WILLIAM J | Chief Financial Off ... | Buy | M | 1.01 | 18,750 | 18,938 | 28,750 | 10 K to 28.8 K (+187.50 %) |
| May 10 2004 | ANIK | Anika Therapeutics ... | KNIGHT WILLIAM J | Chief Financial Off ... | Buy | M | 1.05 | 10,000 | 10,500 | 10,000 | 0 to 10 K |
| Apr 26 2004 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Option Exercise | M | 2.63 | 25,000 | 65,625 | 55,926 | |
| Apr 26 2004 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 9.31 | 23,980 | 223,275 | 30,000 | 54 K to 30 K (-44.42 %) |
| Apr 26 2004 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Buy | M | 2.63 | 25,000 | 65,625 | 53,980 | 29 K to 54 K (+86.27 %) |
| Apr 16 2004 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | S | 8.78 | 7,500 | 65,850 | 0 | 7.5 K to 0 (-100.00 %) |
| Apr 23 2004 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | S | 9.29 | 15,000 | 139,350 | 57,470 | 72.5 K to 57.5 K (-20.70 %) |
| Apr 15 2004 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Option Exercise | M | 2.63 | 17,000 | 44,625 | 55,926 | |
| Apr 15 2004 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Option Exercise | M | 2.63 | 8,000 | 21,000 | 72,926 | |
| Apr 15 2004 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Sell | S | 9.06 | 17,000 | 154,080 | 51,080 | 68.1 K to 51.1 K (-24.97 %) |
| Apr 15 2004 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Buy | M | 2.63 | 17,000 | 44,625 | 68,080 | 51.1 K to 68.1 K (+33.28 %) |
| Apr 15 2004 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Buy | M | 2.63 | 8,000 | 21,000 | 51,080 | 43.1 K to 51.1 K (+18.57 %) |
| Apr 15 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Sell | S | 9.04 | 14,000 | 126,595 | 1,874 | 15.9 K to 1.9 K (-88.19 %) |
| Apr 15 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Sell | S | 9.18 | 15,000 | 137,678 | 15,874 | 30.9 K to 15.9 K (-48.58 %) |
| Dec 19 2003 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Option Exercise | A | 9.22 | 1,530 | 14,107 | 1,530 | |
| Dec 19 2003 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | A | 9.22 | 1,530 | 14,107 | 1,530 | |
| Dec 19 2003 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Option Exercise | A | 9.22 | 1,530 | 14,107 | 1,530 | |
| Dec 19 2003 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Option Exercise | A | 9.22 | 1,530 | 14,107 | 1,530 | |
| Dec 19 2003 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President - Op ... | Option Exercise | A | 9.22 | 30,000 | 276,600 | 30,000 | |
| Dec 19 2003 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Option Exercise | A | 9.22 | 100,000 | 922,000 | 100,000 | |
| Dec 19 2003 | ANIK | Anika Therapeutics ... | KNIGHT WILLIAM J | Chief Financial Off ... | Option Exercise | A | 9.22 | 40,000 | 368,800 | 40,000 | |
| Dec 19 2003 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Option Exercise | A | 9.22 | 1,530 | 14,107 | 1,530 |